Elsevier Inc.

SHERPA: Unknown

People

  1. Kollmeier
    Kollmeier
  2. Zhang
    Zhang
  3. Damato
    Damato
  4. McBride
    McBride
  5. Alektiar
    Alektiar
  6. Aramburu Nunez
    Aramburu Nunez
  7. Brennan
    Brennan
  8. Broach
    Broach
  9. Dave
    Dave
  10. Dreyfuss
    Dreyfuss

Groups

  1. Biostatistics Service (4)
  2. Epidemiology and Biostatistics (4)
  3. GDMT, Radiation Oncology (4)
  4. Gynecology Disease Management Team (4)
  5. Medical Physics (4)
  6. Radiation Oncology, Department of (4)
  7. Survivorship Research (4)
  8. Radiotherapy Physics Service (3)
  9. Sloan Kettering Institute Postdocs (2)
  10. Surgery (2)
Search Within
  1. "Gilad Cohen"
  2. "Epidemiology and Biostatistics"
  3. "Marisa Kollmeier"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (4)
  2. Epidemiology and Biostatistics (4)
  3. GDMT, Radiation Oncology (4)
  4. Gynecology Disease Management Team (4)
  5. Medical Physics (4)
  6. Radiation Oncology, Department of (4)

More Groups

People
  1. Gilad Cohen (4)
  2. Marisa Kollmeier (4)
  3. Zhigang Zhang (4)
  4. Antonio Damato (3)
  5. Michael Zelefsky (3)
  6. Sean McBride (2)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2012 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (3)
  2. Radiotherapy and Oncology (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-brachytherapy diffusion-weighted magnetic resonance imaging (DW-MRI) response as predictor of local control in the definitive treatment of cervical cancer
    Meeting Abstract

    Moore, A.; Paudyal, R.; Elder, G.; Lakhman, Y.; White, C.; Zhang, Z.; Broach, V. A.; Liu, Y.; Damanto, A.; Cohen, G. N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose rate (HDR) vs. low-dose rate (LDR) brachytherapy boost
    Meeting Abstract

    Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V. S.; Beaudry, J.; Cohen, G.; Damato, A. L.; Zhang, Z.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Low-dose-rate brachytherapy combined with ultrahypofractionated radiation therapy for clinically localized, intermediate-risk prostate cancer: Results from a prospective trial
    Journal Article

    Kollmeier, M. A.; McBride, S.; Varghese, M.; Debonis, D.; Zhang, Z.; Cohen, G.; Damato, A. L.; Mychalczak, B.; Gewanter, R.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • V150 predicts erectile outcome in patients undergoing low-dose-rate (LDR) brachytherapy alone for prostate cancer
    Meeting Abstract

    Kollmeier, M. A.; Scala, L. M.; Kunaprayoon, D.; Mathur, N.; Cohen, G.; Pei, X.; Zhang, Z.; Mulhall, J.; Cox, B.; Zelefsky, M. J.
    Radiotherapy and Oncology (2012)

    Fulltext@MSK | Save